People · Operator
Named in public records as an officer, director or promoter · active 2015–2020 · Biotech / Pharma, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PharmaCann Inc. | — | Biotech / Pharma | Series D+ | $509.0M | $413.5M | 2015 |
| MLH MSO Holdco, Inc. | — | Other | Series A | $20.0M | $172.4M | 2019 |
Teddy Scott at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Teddy Scott on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Clapper | 1 | 6 |
| John McCarthy | 1 | 6 |
| William Landman | 1 | 6 |
| James Barry | 1 | 5 |
| John Leja | 1 | 4 |
| Patrick Barry | 1 | 4 |
| Jeff Cook | 1 | 4 |
| John Lord | 1 | 3 |
| Daniel Roth | 1 | 2 |
| Stephen Schuler | 1 | 1 |
| Christina Leja | 1 | 1 |
| Brad Leshnock | 1 | 1 |
| Christina D Leja | 1 | 1 |
| Norah Scott | 1 | 1 |
| Stephen G Schuler | 1 | 1 |
| Teddy C Scott | 1 | 1 |
| John A Leja | 1 | 1 |
| Stephen Patrick Schuler | 1 | 1 |
| John Patrick McCarthy | 1 | 1 |
| John Patrick Lord | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.